- Home
- CPIX vs CATO Comparison
CPIX vs CATO Comparison
Compare CPIX & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- CATO
- Stock Information
- Founded
- CPIX 1999
- CATO 1946
- Country
- CPIX United States
- CATO United States
- Employees
- CPIX N/A
- CATO N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- CATO Clothing/Shoe/Accessory Stores
- Sector
- CPIX Health Care
- CATO Consumer Discretionary
- Exchange
- CPIX Nasdaq
- CATO Nasdaq
- Market Cap
- CPIX 48.5M
- CATO 57.6M
- IPO Year
- CPIX 2009
- CATO N/A
- Fundamental
- Price
- CPIX $3.23
- CATO $4.64
- Analyst Decision
- CPIX
- CATO
- Analyst Count
- CPIX 0
- CATO 0
- Target Price
- CPIX N/A
- CATO N/A
- AVG Volume (30 Days)
- CPIX 32.7K
- CATO 204.6K
- Earning Date
- CPIX 11-06-2025
- CATO 08-21-2025
- Dividend Yield
- CPIX N/A
- CATO N/A
- EPS Growth
- CPIX N/A
- CATO N/A
- EPS
- CPIX N/A
- CATO N/A
- Revenue
- CPIX $42,071,813.00
- CATO $650,830,000.00
- Revenue This Year
- CPIX N/A
- CATO N/A
- Revenue Next Year
- CPIX N/A
- CATO N/A
- P/E Ratio
- CPIX N/A
- CATO N/A
- Revenue Growth
- CPIX 11.34
- CATO N/A
- 52 Week Low
- CPIX $1.04
- CATO $2.19
- 52 Week High
- CPIX $7.25
- CATO $6.70
- Technical
- Relative Strength Index (RSI)
- CPIX 43.51
- CATO 68.86
- Support Level
- CPIX $3.26
- CATO $3.84
- Resistance Level
- CPIX $3.57
- CATO $4.73
- Average True Range (ATR)
- CPIX 0.20
- CATO 0.26
- MACD
- CPIX -0.01
- CATO -0.00
- Stochastic Oscillator
- CPIX 4.17
- CATO 73.33
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.